- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
43
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
43 companies
Influx Healthtech
Market Cap: ₹4.5b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹195.05
7D
0.8%
1Y
n/a
Arab Drug
Market Cap: ج.م2.2b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م182.09
7D
2.6%
1Y
298.1%
Pharmedic Pharmaceutical Medicinal
Market Cap: ₫975.3b
Engages in the manufacture and trade of pharmaceutical products, medicinal materials, cosmetics, medical supplies, and other products in Vietnam.
PMC
₫105,000.00
7D
1.0%
1Y
18.0%
Simply Solventless Concentrates
Market Cap: CA$33.5m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.31
7D
8.8%
1Y
-35.4%
Asston Pharmaceuticals
Market Cap: ₹867.5m
Engages in the manufacturing and selling of pharmaceutical formulations and nutraceutical products in India, West Africa, South Africa, and rest of Asia.
544445
₹101.90
7D
-4.8%
1Y
n/a
Accretion Pharmaceuticals
Market Cap: ₹707.5m
Engages in the manufacturing and marketing of pharmaceutical products in India.
ACCPL
₹63.65
7D
1.0%
1Y
n/a
Genesis IBRC India
Market Cap: ₹695.4m
Does not have significant operations.
514336
₹53.49
7D
15.7%
1Y
n/a